Zhou, X. et al. (75) reported that IL-33 inhibited the expression of cell death-inducing p53 target protein 1 (CDIP1) by regulating the miR-128-3p/CDIP1 signaling pathway, thereby effectively reducing the apoptosis of NSCLC cells. Here, IL33 is linked to non-small cell lung carcinoma.